Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

2.72
Delayed Data
As of Feb 17
 -0.04 / -1.45%
Today’s Change
1.83
Today|||52-Week Range
14.80
+32.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization45.8K50.4K47.7K36.2K
 
 
 
 
 
 
Operating ExpensesGross Income-45.8K-50.4K-47.7K-36.2K
 
 
 
 
 
General Expenses11.8M9.4M9.8M15.5M
 
 
 
 
 
Research And Development7.7M5.3M6.0M10.9M
 
 
 
 
 
Total Operating Expenses11.8M9.5M9.9M15.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.8M-9.5M-9.9M-15.5M
 
 
 
 
 
Extraordinary Credit0.00642.4K529.8K2.9M
 
 
 
 
Extraordinary Charge-2.3M0.00--0.00
 
 
Interest Expense On Debt------222.8K
 
 
Other Expenses-397.3K0.00-62.7K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.5M-8.8M-9.4M-12.8M
 
 
 
 
 
Net Income-14.5M-8.8M-9.4M-12.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.0M1.4M1.5M2.2M
 
 
 
 
 
Shares To Calculate EPS Diluted1.0M1.4M1.5M2.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$14.00-$6.40-$6.40-$6.00
 
 
 
 
 
EPS Diluted-$14.00-$6.40-$6.40-$6.00